BIOTRONIK Evia DR, Technical Manual

Page: 110 / 183

102 Evia Technical Manual
Home Monitoring can be utilized as a functional replacement for
in-office follow-up visits and allows the time between routine,
scheduled, in-office follow-ups of BIOTRONIK implantable
devices to be extended to twelve months or more. Home
Monitoring evaluation of implanted devices and patient status is
as safe as conventional in-office follow-ups. BIOTRONIK’s
Home Monitoring system provides early detection of arrhythmic
events and of silent, asymptomatic events. Automatic early
detection of clinical events by Home Monitoring leads to earlier
intervention than conventional in-office follow-ups and improves
adherence to scheduled follow-ups.
N
OTE
:
When ERI mode is reached, this status is transmitted.
Further measurements and transmissions of Home
Monitoring data are no longer possible.
7.15.1 Transmission of Information
The implant transmits information with a small transmitter, which
has a range of about 6 feet (2 meters). The patient’s implant
data are sent to the corresponding patient device in configurable
periodic intervals.
The minimal distance between the implant and the patient device
must be 6 inches (15 cm).
7.15.2 Patient Device
The patient device (
Figure 18
) is designed for use in or away
from the home and is comprised of the mobile unit and the
associated charging station. The patient can carry the mobile
unit during his or her occupational and leisure activities. The
patient device is rechargeable, allowing for an approximate
operational time of 24 hours. It receives information from the
implant and forwards it via the cellular mobile network or the
standard telephone system to a BIOTRONIK Service Center.
For additional information about the patient device, please refer
to its manual.